Status:
COMPLETED
Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine
Lead Sponsor:
University of South Florida
Conditions:
Endometritis
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Endomyometritis is an "infection in the uterus". It can occur in up to 1 out of 5 women having unplanned cesarean deliveries. Antibiotics are routinely given at the time of Cesarean delivery, but the ...
Eligibility Criteria
Inclusion
- Female singleton gravidas
- Patients receiving non-elective cesarean deliveries after trial of labor
- No evidence of chorioamnionitis
Exclusion
- Diagnosis of chorioamnionitis
- Elective cesarean section
- Unable to provide informed consent
- Immunocompromised patients and those on antiretroviral drugs
- Patients with known infection
- Hypertension (blood pressure greater than 140/90 x 2, six hours apart), including those with a past history, gestational or Preeclampsia.
- Allergic to ergot alkaloids. This would include people allergic to migraine medicine.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00858832
Start Date
December 1 2008
End Date
January 1 2011
Last Update
September 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampa General Hospital
Tampa, Florida, United States, 33602